Homepage

Field officers survey households in rural Kenya.

Stories / Global Impact

Novartis invites scrutiny of effort to improve access to medicine

Public health expert Richard Laing discusses how independent measurement of access programs can help ...

Stories / Global Impact

The specter of malaria that resists treatment

Great progress has been made against malaria, but signs of resistance are becoming a rising concern ...

Blood smear from patient with African Sleeping sickness (Centers for Disease Control and Prevention)

Stories / Discovery

Killing three diseases with one stone in the lab

Novartis researchers have discovered a compound that is showing promise against three parasites that ...

Leukemia cells attacked from two angles.

Stories / Discovery

Striving to vanquish leukemia

Combination of two compounds shows promise in the lab

Explore Novartis

About Us

Corporate Responsibility

Research & Development

Clinical Pipeline

Recent Updates

Featured / May 12

Novartis Access and government of Pakistan sign memorandum of understanding

Novartis reaches agreement with Pakistan to increase access to medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation.

Read the news

Media Release / May 17

Novartis Foundation and partners launch initiative to tackle hypertension and its root causes in low-income urban communities

Media Release / May 11

Novartis celebrates 21st annual Community Partnership Day with over 24,500 associates volunteering in their local communities

In The News / May 10

Novartis Access perspective: The key to fighting chronic disease in South-East Asia - young people

View All

The #FDA has approved first-line use of a #Novartis therapy for certain patients w/ #NSCLC https://t.co/NDO6796D10. 21 hours 14 min ago

RT @NCDAccess: @AnnAerts discusses new @NovartisFDN initiative #BetterHeartsBetterCities. designed to tackling hypertension in… https://t.co/T6eGquazAK 2 days 5 hours ago

RT @NCDAccess: "We co-design intervention with patients, health communities & policy makers" - @AnnAertsNF, @NovartisFDN discussin… https://t.co/IKxgEtAnJi 2 days 5 hours ago

Our Business

Novartis focuses its business on three divisions with innovation power and global scale: innovative medicines, eye care and generics.

Learn More